NEW CASE STUDIES: SEE HOW NUSHIELD® HELPED TO SUPPORT HEALING

Real-world evidence

Caporusso et al case series1

In real-world patients (retrospective case series), NuShield® was used as a covering in a wide variety of wounds (N=50), including VLUs (n=14), DFUs (n=24), and other wounds (pressure ulcers, nonhealing surgical, ischemic, mixed etiology, and nonhealing amputation; n=12).1

DFU=diabetic foot ulcer; VLU=venous leg ulcer

Median time to wound closure1

Estimated median time to complete wound closure for wounds from a Cox regression model with terms for age, sex, wound type, wound duration, baseline wound area, and duration in clinic. Test of equality over strata: P=0.071 (Wilcoxon). *All wounds includes DFUs, VLUs, and other wounds. Other includes 3 pressure injuries; 4 nonhealing surgical, 1 ischemic, and 1 mixed etiology wound; 1 nonhealing amputation; and 1 not identified.1

Percentage of wounds closed by week1

Estimated frequency of complete wound closure for wounds from a Cox regression model with terms for age, sex, wound type, wound duration, baseline wound area, and duration in clinic. Test of equality over strata: P=0.071 (Wilcoxon). *All wounds includes DFUs, VLUs, and other wounds. Other includes 3 pressure injuries; 4 nonhealing surgical, 1 ischemic, and 1 mixed etiology wound; 1 nonhealing amputation; and 1 not identified.1

Of those wounds that did not achieve wound closure, 9 (18%) had >90% wound closure, and 8 (16%) had wound closures ranging from 60% to 90% by the last observation.1

Composition comparison for NuShield

See the results comparing NuShield to another commercially available dHACM, or talk to an Organogenesis Tissue Regeneration Specialist about the dehydrated placental allograft wound covering that retains all native layers.

Contact us

NuShield is intended to be used as a wound covering and barrier.
Please refer to the NuShield instructions for use for usage and safety information.

REFERENCE:

  1. Caporusso J, et al. Wounds. 2019;31(4 Suppl):S19-S27.